Jul 26 2022 |
Litigation Minute: Red Lobster Complaint Highlights Threat of ESG Litigation to The Food and Beverage Industry |
K&L Gates LLP |
Jul 26 2022 |
Chocolate False Advertisement Lawsuit Dismissed |
Keller and Heckman LLP |
Jul 25 2022 |
EU Court of Justice on GMO Crop Ban |
Keller and Heckman LLP |
Jul 25 2022 |
The French Decree on the Prohibition of Meat Designations for Plant-based Products |
Keller and Heckman LLP |
Jul 25 2022 |
My Mississippi Medical Cannabis Gran Fondo — The Wheel Is Turning and You Can’t Slow Down |
Bradley Arant Boult Cummings LLP |
Jul 25 2022 |
SAB PFAS Hearing Delivered News of Wider PFAS Regulation Possibility |
CMBG3 Law |
Jul 25 2022 |
Life Sciences in the Metaverse: A New Forum |
ArentFox Schiff LLP |
Jul 25 2022 |
Proposed Rule Could Make Sugarcane Subject to the Same National Bioengineered Food Disclosure Standard Burdens as Sugarbeet |
Keller and Heckman LLP |
Jul 22 2022 |
McDermottPlus Check-Up: July 22, 2022 |
McDermott Will & Schulte LLP |
Jul 22 2022 |
FSIS Puts Cell-Cultured Meat Labeling Regulations On Hold |
Keller and Heckman LLP |
Jul 21 2022 |
FDA Issues Final Guidance on Drug and Biological Instructions for Use (IFU) |
Sheppard, Mullin, Richter & Hampton LLP |
Jul 21 2022 |
FDA Publishes RFI on Fluorinated Polyethylene Containers for Food Contact Use |
Bergeson & Campbell, P.C. |
Jul 21 2022 |
FDA Evaluation of Agency Activities |
Keller and Heckman LLP |
Jul 21 2022 |
FDA PFAS Action Targets Food Packaging |
CMBG3 Law |
Jul 21 2022 |
District of Columbia Provides Employment Protections for Off-Duty Cannabis Use |
Polsinelli PC |
Jul 21 2022 |
South Korea Promotes Alternative Proteins in Its National Plan |
Keller and Heckman LLP |
Jul 20 2022 |
Will a Nonprescription Birth Control Pill Be FDA’s First Approval under its Long-Awaited “ANCU” Proposed Rule? |
Mintz |
Jul 20 2022 |
Physician Fee Schedule Proposed Rule for 2023 Released: What Pharmaceutical Manufacturers Need To Know |
ArentFox Schiff LLP |
Jul 20 2022 |
Down on the Farm: After Public Hearing, Alabama Department of Agriculture and Industries Finalizes Medical Cannabis Cultivation Rules |
Bradley Arant Boult Cummings LLP |
Jul 20 2022 |
OECD Publishes Project Report on Chemical Accidents Involving Nanomaterials |
Bergeson & Campbell, P.C. |
Jul 20 2022 |
Bill Introduced to Establish Single Food Safety Agency |
Keller and Heckman LLP |
Jul 19 2022 |
SCOTUS 340B Decision Drives CMS to Restore Part B 340B Payments and Seek Comments on Remedies in the CY 2023 OPPS Proposed Rule |
Polsinelli PC |
Jul 19 2022 |
FDA Proposes Compliance Dates for Pre-Harvest Agricultural Water Requirements and Specifies Duration of Enforcement Discretion for Harvest and Post-Harvest Requirements |
Keller and Heckman LLP |
Jul 19 2022 |
A Third Surge in Innovation and Patents on Hydrogen Fuel Cell Vehicles |
Foley & Lardner LLP |
Jul 18 2022 |
Target Argues Consumer Deception is Implausible for Bright Red, Zero-Calorie, Water Enhancer |
Keller and Heckman LLP |
Jul 18 2022 |
EC Requests Scientific Opinion on Titanium Dioxide in Cosmetic Products |
Bergeson & Campbell, P.C. |
Jul 18 2022 |
Camp Lejeune Water Contamination Lawsuits |
Buckfire Law |
Jul 18 2022 |
Kardashian’s ‘SKKN by Kim’ Brand Facing Legal Uncertainty |
Proskauer Rose LLP |
Jul 18 2022 |
The Waiting Is the Hardest Part: Alabama Medical Cannabis Commission Announces Updated Timetable for Licenses |
Bradley Arant Boult Cummings LLP |
Jul 18 2022 |
Commission Approves State Aid For IPCEI In Hydrogen |
K&L Gates LLP |
Jul 16 2022 |
FDA Greenlights Pharmacists to Prescribe COVID-19 Drug Paxlovid |
Epstein Becker & Green, P.C. |
Jul 15 2022 |
Austrian Academy of Sciences Publishes NanoTrust Dossier on Advanced Materials |
Bergeson & Campbell, P.C. |
Jul 15 2022 |
In Mexico, a Reform Project Is Being Discussed That Contains Restrictive Measures for the Advertising and Marketing of Products Containing Tobacco |
OLIVARES |
Jul 15 2022 |
New FDA Draft Guidance Aiming to Prevent Drug Shortages Will Affect Pharmaceutical Manufacturers |
K&L Gates LLP |
Jul 15 2022 |
Gerber Argues FDA Preemption in Baby Food Lawsuit |
Keller and Heckman LLP |